Read More

Federal health agency acknowledges potential medical benefits of psilocybin in new PSA webpage

A new webpage apparently posted within the past week by a federal U.S. health agency acknowledges that psilocybin may have medical value, particularly for treating depression, despite its current status as a federally banned Schedule I drug. The page, “Psilocybin for Mental Health and Addiction: What You Need to Know,” …